ANIX logo

Anixa Biosciences (ANIX) Cash From Financing

Annual CFF

$3.42 M
+$3.05 M+833.06%

October 1, 2024

Summary

Performance

1-Year Change

+833.06%

3-Year Change

-89.18%

5-Year Change

-40.12%

15-Year Change

-53.74%

ANIX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.72%
ANIX annual cash flow from financing activities is higher than 43.72% of companies in Healthcare sector

High & Low

All-time High

$31.57 M
ANIX annual cash flow from financing activities is currently -89.18% below its historical high of $31.57 million

3-Year Low

$366.00 K
ANIX annual cash flow from financing activities is currently +833.06% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Oct 1, 2024
ANIX previous annual earnings announcement was published on Oct 1, 2024

Next Annual Earnings Report Date

N/A
ANIX next annual earnings announcement has not yet been scheduled

OtherANIXcash flowmetrics:

Annual CFI

$4.28 M
ANIX annual cash flow from investing activities is $4.28 million

Annual CFO

-$7.33 M
ANIX annual cash flow from operations is -$7.33 million

Annual FCF

-$7.33 M
ANIX annual free cash flow is -$7.33 million

Annual CAPEX

-
ANIX annual capital expenditures value is unknown

Quarterly CFF

$106.00 K
-$43.00 K-28.86%

October 1, 2024

Summary

Performance

3-Month Change

-28.86%

1-Year Change

-62.01%

3-Year Change

+3433.33%

5-Year Change

+3433.33%

ANIX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.36%
ANIX quarterly cash flow from financing activities is higher than 52.36% of companies in Healthcare sector

High & Low

All-time High

$25.36 M
ANIX quarterly cash flow from financing activities is currently -99.58% below its historical high of $25.36 million

3-Year Low

-$384.00 K

Earnings dates

Last Quarterly Earnings Report Date

Oct 1, 2024
ANIX previous earnings announcement was published on Oct 1, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
ANIX next earnings announcement is scheduled for Mar 12, 2025

OtherANIXcash flowmetrics:

Quarterly CFI

$867.00 K
ANIX quarterly cash flow from investing activities is $867.00 thousand

Quarterly CFO

-$927.00 K
ANIX quarterly cash flow from operations is -$927.00 thousand

Quarterly FCF

-$927.00 K
ANIX quarterly free cash flow is -$927.00 thousand

Quarterly CAPEX

-
ANIX quarterly capital expenditures value is unknown

TTM CFF

$3.42 M
-$173.00 K-4.82%

October 1, 2024

Summary

Performance

3-Month Change

-4.82%

1-Year Change

+833.06%

3-Year Change

+1249.83%

5-Year Change

+1249.83%

ANIX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.88%
ANIX TTM cash flow from financing activities is higher than 38.88% of companies in Healthcare sector

High & Low

All-time High

$37.68 M
ANIX TTM cash flow from financing activities is currently -90.94% below its historical high of $37.68 million

3-Year Low

-$297.00 K

Earnings dates

Last Quarterly Earnings Report Date

Oct 1, 2024
ANIX previous earnings announcement was published on Oct 1, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
ANIX next earnings announcement is scheduled for Mar 12, 2025

OtherANIXcash flowmetrics:

TTM CFI

$4.28 M
ANIX TTM cash flow from investing activities is $4.28 million

TTM CFO

-$7.33 M
ANIX TTM cash flow from operations is -$7.33 million

TTM FCF

-$7.33 M
ANIX TTM free cash flow is -$7.33 million

TTM CAPEX

-
ANIX TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ANIX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+833.1%-62.0%+833.1%
3 y3 years-89.2%+3433.3%+1249.8%
5 y5 years-40.1%+3433.3%+1249.8%

ANIX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-89.2%+833.1%-95.3%+127.6%-86.6%+1249.8%
5 y5-year-89.2%+833.1%-99.6%+127.6%-90.9%+1249.8%
alltimeall time-89.2%+952.5%-99.6%+121.4%-90.9%+787.1%

Anixa Biosciences Cash From Financing History

DateAnnualQuarterlyTTM
Oct 2024
$3.42 M(+833.1%)
$106.00 K(-28.9%)
$3.42 M(-4.8%)
Jul 2024
-
$149.00 K(-83.4%)
$3.59 M(+4.2%)
Apr 2024
-
$897.00 K(-60.4%)
$3.44 M(+31.1%)
Jan 2024
-
$2.26 M(+711.1%)
$2.63 M(+617.5%)
Oct 2023
$366.00 K(-19.0%)
$279.00 K(+9200.0%)
$366.00 K(-223.2%)
Jul 2023
-
$3000.00(-96.3%)
-$297.00 K(-156.1%)
Apr 2023
-
$81.00 K(+2600.0%)
$529.00 K(+16.3%)
Jan 2023
-
$3000.00(-100.8%)
$455.00 K(+0.7%)
Oct 2022
$452.00 K(-98.6%)
-$384.00 K(-146.3%)
$452.00 K(-53.9%)
Jul 2022
-
$829.00 K(>+9900.0%)
$980.00 K(+549.0%)
Apr 2022
-
$7000.00(>+9900.0%)
$151.00 K(-99.4%)
Jan 2022
-
$0.00(-100.0%)
$25.50 M(-19.2%)
Oct 2021
$31.57 M(+235.6%)
$144.00 K(>+9900.0%)
$31.57 M(-3.8%)
Jul 2021
-
$0.00(-100.0%)
$32.83 M(-12.9%)
Apr 2021
-
$25.36 M(+318.4%)
$37.68 M(+175.3%)
Jan 2021
-
$6.06 M(+332.0%)
$13.69 M(+45.5%)
Oct 2020
$9.41 M(+65.0%)
$1.40 M(-71.1%)
$9.41 M(+8.3%)
Jul 2020
-
$4.85 M(+253.4%)
$8.69 M(+97.4%)
Apr 2020
-
$1.37 M(-22.9%)
$4.40 M(-17.1%)
Jan 2020
-
$1.78 M(+161.1%)
$5.31 M(-6.9%)
Oct 2019
$5.70 M(+125.6%)
$681.80 K(+20.8%)
$5.70 M(-1.0%)
Jul 2019
-
$564.60 K(-75.2%)
$5.76 M(-8.6%)
Apr 2019
-
$2.28 M(+4.8%)
$6.31 M(+34.1%)
Jan 2019
-
$2.18 M(+193.2%)
$4.70 M(+86.1%)
Oct 2018
$2.53 M(-65.8%)
$742.30 K(-33.0%)
$2.53 M(-22.2%)
Jul 2018
-
$1.11 M(+63.7%)
$3.25 M(-25.4%)
Apr 2018
-
$677.40 K(>+9900.0%)
$4.35 M(-44.8%)
Jan 2018
-
$0.00(-100.0%)
$7.88 M(+6.7%)
Oct 2017
$7.38 M(<-9900.0%)
$1.46 M(-33.9%)
$7.38 M(+25.2%)
Jul 2017
-
$2.21 M(-47.4%)
$5.89 M(+59.8%)
Apr 2017
-
$4.20 M(-950.4%)
$3.69 M(-842.1%)
Jan 2017
-
-$494.30 K(+1793.9%)
-$497.00 K(>+9900.0%)
Oct 2016
-$2700.00(-99.3%)
-$26.10 K(-601.9%)
-$2700.00(-108.0%)
Jul 2016
-
$5200.00(-71.4%)
$33.70 K(-118.5%)
Apr 2016
-
$18.20 K(>+9900.0%)
-$182.40 K(-54.5%)
Jan 2016
-
$0.00(-100.0%)
-$400.60 K(0.0%)
Oct 2015
-$400.60 K(-105.5%)
$10.30 K(-104.9%)
-$400.60 K(+3.7%)
Jul 2015
-
-$210.90 K(+5.5%)
-$386.30 K(-110.4%)
Apr 2015
-
-$200.00 K(-913.0%)
$3.70 M(-49.7%)
Oct 2014
$7.35 M(+126.4%)
$24.60 K(-99.4%)
$7.35 M(-5.6%)
Jul 2014
-
$3.87 M(-7957.4%)
$7.78 M(+74.5%)
Apr 2014
-
-$49.30 K(-101.4%)
$4.46 M(-10.5%)
Jan 2014
-
$3.50 M(+660.0%)
$4.98 M(+53.5%)
Oct 2013
$3.25 M(+238.7%)
$460.50 K(-16.1%)
$3.25 M(-8.2%)
Jul 2013
-
$549.00 K(+16.5%)
$3.54 M(+18.4%)
Apr 2013
-
$471.40 K(-73.3%)
$2.99 M(+15.9%)
Jan 2013
-
$1.76 M(+135.3%)
$2.58 M(+168.8%)
Oct 2012
$958.50 K(-62.2%)
$750.00 K(>+9900.0%)
$958.40 K(+143.5%)
Jul 2012
-
$0.00(-100.0%)
$393.60 K(-57.0%)
Apr 2012
-
$61.20 K(-58.4%)
$915.00 K(-58.5%)
Jan 2012
-
$147.20 K(-20.5%)
$2.20 M(-13.0%)
Oct 2011
$2.53 M(+102.9%)
$185.20 K(-64.5%)
$2.53 M(-0.6%)
Jul 2011
-
$521.40 K(-61.4%)
$2.55 M(+14.7%)
Apr 2011
-
$1.35 M(+182.5%)
$2.22 M(+86.0%)
Jan 2011
-
$477.80 K(+139.5%)
$1.19 M(-4.3%)
Oct 2010
$1.25 M(-36.7%)
$199.50 K(+2.0%)
$1.25 M(-29.6%)
Jul 2010
-
$195.50 K(-39.3%)
$1.77 M(-14.3%)
Apr 2010
-
$322.00 K(-39.5%)
$2.07 M(-0.4%)
Jan 2010
-
$532.00 K(-26.5%)
$2.08 M(+5.4%)
Oct 2009
$1.97 M(-89.5%)
$724.10 K(+47.3%)
$1.97 M(+19.3%)
Jul 2009
-
$491.50 K(+48.6%)
$1.65 M(+5.3%)
Apr 2009
-
$330.70 K(-22.4%)
$1.57 M(-18.7%)
Jan 2009
-
$425.90 K(+5.2%)
$1.93 M(-89.7%)
Oct 2008
$18.71 M(+766.4%)
$405.00 K(-0.9%)
$18.71 M(-0.8%)
Jul 2008
-
$408.70 K(-40.9%)
$18.86 M(+0.0%)
Apr 2008
-
$692.00 K(-96.0%)
$18.86 M(+1.2%)
Jan 2008
-
$17.21 M(+3015.4%)
$18.63 M(+762.5%)
Oct 2007
$2.16 M
$552.30 K(+36.2%)
$2.16 M(-4.8%)
Jul 2007
-
$405.40 K(-12.7%)
$2.27 M(-2.5%)
Apr 2007
-
$464.50 K(-37.0%)
$2.33 M(-3.3%)
DateAnnualQuarterlyTTM
Jan 2007
-
$737.60 K(+11.4%)
$2.41 M(+1.1%)
Oct 2006
$2.38 M(+46.2%)
$662.00 K(+42.6%)
$2.38 M(+15.0%)
Jul 2006
-
$464.30 K(-14.6%)
$2.07 M(+4.3%)
Apr 2006
-
$543.50 K(-23.5%)
$1.99 M(+6.6%)
Jan 2006
-
$710.70 K(+101.7%)
$1.86 M(+14.4%)
Oct 2005
$1.63 M(+35.7%)
$352.40 K(-7.1%)
$1.63 M(-0.7%)
Jul 2005
-
$379.20 K(-9.8%)
$1.64 M(+14.0%)
Apr 2005
-
$420.50 K(-11.8%)
$1.44 M(-8.1%)
Jan 2005
-
$476.50 K(+31.0%)
$1.57 M(+30.5%)
Oct 2004
$1.20 M(+6.4%)
$363.70 K(+104.7%)
$1.20 M(+4.7%)
Jul 2004
-
$177.70 K(-67.6%)
$1.15 M(-32.5%)
Apr 2004
-
$547.70 K(+394.3%)
$1.70 M(+40.9%)
Jan 2004
-
$110.80 K(-64.3%)
$1.20 M(+6.8%)
Oct 2003
$1.13 M(>+9900.0%)
$310.00 K(-57.4%)
$1.13 M(+37.9%)
Jul 2003
-
$728.50 K(+1212.6%)
$818.20 K(+737.5%)
Apr 2003
-
$55.50 K(+62.3%)
$97.70 K(+131.5%)
Jan 2003
-
$34.20 K(>+9900.0%)
$42.20 K(+427.5%)
Oct 2002
$8000.00(-99.0%)
$0.00(-100.0%)
$8000.00(0.0%)
Jul 2002
-
$8000.00(>+9900.0%)
$8000.00(-93.2%)
Apr 2002
-
$0.00(0.0%)
$118.00 K(-63.2%)
Jan 2002
-
$0.00(0.0%)
$320.40 K(-60.9%)
Oct 2001
$819.80 K(-79.6%)
$0.00(-100.0%)
$819.80 K(0.0%)
Jul 2001
-
$118.00 K(-41.7%)
$819.80 K(-9.1%)
Apr 2001
-
$202.40 K(-59.5%)
$901.80 K(-74.4%)
Jan 2001
-
$499.40 K(>+9900.0%)
$3.53 M(-12.4%)
Oct 2000
$4.03 M(+43.8%)
$0.00(-100.0%)
$4.03 M(-18.3%)
Jul 2000
-
$200.00 K(-92.9%)
$4.93 M(-3.9%)
Apr 2000
-
$2.83 M(+182.6%)
$5.13 M(+70.9%)
Jan 2000
-
$1.00 M(+11.1%)
$3.00 M(+7.1%)
Oct 1999
$2.80 M(>+9900.0%)
$900.00 K(+125.0%)
$2.80 M(+47.4%)
Jul 1999
-
$400.00 K(-42.9%)
$1.90 M(+26.7%)
Apr 1999
-
$700.00 K(-12.5%)
$1.50 M(+87.5%)
Jan 1999
-
$800.00 K(>+9900.0%)
$800.00 K(>+9900.0%)
Oct 1998
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Jul 1998
-
$0.00(0.0%)
$300.00 K(-25.0%)
Apr 1998
-
$0.00(0.0%)
$400.00 K(-75.0%)
Jan 1998
-
$0.00(-100.0%)
$1.60 M(-11.1%)
Oct 1997
$1.80 M(-90.4%)
$300.00 K(+200.0%)
$1.80 M(-50.0%)
Jul 1997
-
$100.00 K(-91.7%)
$3.60 M(-71.9%)
Apr 1997
-
$1.20 M(+500.0%)
$12.80 M(-22.0%)
Jan 1997
-
$200.00 K(-90.5%)
$16.40 M(-12.8%)
Oct 1996
$18.80 M(+213.3%)
$2.10 M(-77.4%)
$18.80 M(+5.0%)
Jul 1996
-
$9.30 M(+93.8%)
$17.90 M(+54.3%)
Apr 1996
-
$4.80 M(+84.6%)
$11.60 M(+34.9%)
Jan 1996
-
$2.60 M(+116.7%)
$8.60 M(+43.3%)
Oct 1995
$6.00 M(+275.0%)
$1.20 M(-60.0%)
$6.00 M(+22.4%)
Jul 1995
-
$3.00 M(+66.7%)
$4.90 M(+69.0%)
Apr 1995
-
$1.80 M(>+9900.0%)
$2.90 M(+81.3%)
Jan 1995
-
$0.00(-100.0%)
$1.60 M(0.0%)
Oct 1994
$1.60 M(-76.8%)
$100.00 K(-90.0%)
$1.60 M(-44.8%)
Jul 1994
-
$1.00 M(+100.0%)
$2.90 M(-35.6%)
Apr 1994
-
$500.00 K(>+9900.0%)
$4.50 M(-10.0%)
Jan 1994
-
$0.00(-100.0%)
$5.00 M(-27.5%)
Oct 1993
$6.90 M(+305.9%)
$1.40 M(-46.2%)
$6.90 M(+15.0%)
Jul 1993
-
$2.60 M(+160.0%)
$6.00 M(+66.7%)
Apr 1993
-
$1.00 M(-47.4%)
$3.60 M(+16.1%)
Jan 1993
-
$1.90 M(+280.0%)
$3.10 M(+82.4%)
Oct 1992
$1.70 M(+21.4%)
$500.00 K(+150.0%)
$1.70 M(0.0%)
Jul 1992
-
$200.00 K(-60.0%)
$1.70 M(-5.6%)
Apr 1992
-
$500.00 K(0.0%)
$1.80 M(+12.5%)
Jan 1992
-
$500.00 K(0.0%)
$1.60 M(+14.3%)
Oct 1991
$1.40 M(+27.3%)
$500.00 K(+66.7%)
$1.40 M(+16.7%)
Jul 1991
-
$300.00 K(0.0%)
$1.20 M(+9.1%)
Apr 1991
-
$300.00 K(0.0%)
$1.10 M(0.0%)
Jan 1991
-
$300.00 K(0.0%)
$1.10 M(0.0%)
Oct 1990
$1.10 M(-66.7%)
$300.00 K(+50.0%)
$1.10 M(+37.5%)
Jul 1990
-
$200.00 K(-33.3%)
$800.00 K(+33.3%)
Apr 1990
-
$300.00 K(0.0%)
$600.00 K(+100.0%)
Jan 1990
-
$300.00 K
$300.00 K
Oct 1989
$3.30 M
-
-

FAQ

  • What is Anixa Biosciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Anixa Biosciences?
  • What is Anixa Biosciences annual CFF year-on-year change?
  • What is Anixa Biosciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Anixa Biosciences?
  • What is Anixa Biosciences quarterly CFF year-on-year change?
  • What is Anixa Biosciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Anixa Biosciences?
  • What is Anixa Biosciences TTM CFF year-on-year change?

What is Anixa Biosciences annual cash flow from financing activities?

The current annual CFF of ANIX is $3.42 M

What is the all time high annual CFF for Anixa Biosciences?

Anixa Biosciences all-time high annual cash flow from financing activities is $31.57 M

What is Anixa Biosciences annual CFF year-on-year change?

Over the past year, ANIX annual cash flow from financing activities has changed by +$3.05 M (+833.06%)

What is Anixa Biosciences quarterly cash flow from financing activities?

The current quarterly CFF of ANIX is $106.00 K

What is the all time high quarterly CFF for Anixa Biosciences?

Anixa Biosciences all-time high quarterly cash flow from financing activities is $25.36 M

What is Anixa Biosciences quarterly CFF year-on-year change?

Over the past year, ANIX quarterly cash flow from financing activities has changed by -$173.00 K (-62.01%)

What is Anixa Biosciences TTM cash flow from financing activities?

The current TTM CFF of ANIX is $3.42 M

What is the all time high TTM CFF for Anixa Biosciences?

Anixa Biosciences all-time high TTM cash flow from financing activities is $37.68 M

What is Anixa Biosciences TTM CFF year-on-year change?

Over the past year, ANIX TTM cash flow from financing activities has changed by +$3.05 M (+833.06%)